These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 14678378)
41. Apomorphine for the Treatment of Erectile Dysfunction: Systematic Review and Meta-Analysis. Guillén V; Rueda JR; Lopez-Argumedo M; Solà I; Ballesteros J Arch Sex Behav; 2020 Nov; 49(8):2963-2979. PubMed ID: 32964351 [TBL] [Abstract][Full Text] [Related]
42. Ten-year follow-up of sildenafil use in spinal cord-injured patients with erectile dysfunction. Lombardi G; Macchiarella A; Cecconi F; Del Popolo G J Sex Med; 2009 Dec; 6(12):3449-57. PubMed ID: 19686427 [TBL] [Abstract][Full Text] [Related]
43. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction. Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479 [TBL] [Abstract][Full Text] [Related]
44. Treatments for erectile dysfunction in spinal cord patients: alternatives to phosphodiesterase type 5 inhibitors? A review study. Lombardi G; Musco S; Wyndaele JJ; Del Popolo G Spinal Cord; 2015 Dec; 53(12):849-54. PubMed ID: 26193811 [TBL] [Abstract][Full Text] [Related]
45. The evaluation of apomorphine for the treatment of erectile dysfunction. Mohee A; Bretsztajn L; Eardley I Expert Opin Drug Metab Toxicol; 2012 Nov; 8(11):1447-53. PubMed ID: 22998347 [TBL] [Abstract][Full Text] [Related]
46. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury. Bodner DR; Haas CA; Krueger B; Seftel AD Urology; 1999 Jan; 53(1):199-202. PubMed ID: 9886612 [TBL] [Abstract][Full Text] [Related]
47. A prospective evaluation of efficacy and compliance with a multistep treatment approach for erectile dysfunction in patients after non-nerve sparing radical prostatectomy. Gontero P; Fontana F; Zitella A; Montorsi F; Frea B BJU Int; 2005 Feb; 95(3):359-65. PubMed ID: 15679794 [TBL] [Abstract][Full Text] [Related]
48. Role of clinical neurophysiological tests in evaluation of erectile dysfunction in people with spinal cord disorders. Ashraf VV; Taly AB; Nair KP; Rao S; Sridhar Neurol India; 2005 Mar; 53(1):32-5; discussion 35-6. PubMed ID: 15805652 [TBL] [Abstract][Full Text] [Related]
49. Ten years of phosphodiesterase type 5 inhibitors in spinal cord injured patients. Lombardi G; Macchiarella A; Cecconi F; Del Popolo G J Sex Med; 2009 May; 6(5):1248-58. PubMed ID: 19210710 [TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of oral sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord injury. Derry FA; Dinsmore WW; Fraser M; Gardner BP; Glass CA; Maytom MC; Smith MD Neurology; 1998 Dec; 51(6):1629-33. PubMed ID: 9855514 [TBL] [Abstract][Full Text] [Related]
51. The conditioned response erection (CRE)--a new approach to modelling erectile responses in the rat. Brien SE; Wilson E; Heaton JP; Adams MA Int J Impot Res; 2000 Apr; 12(2):91-6. PubMed ID: 11052634 [TBL] [Abstract][Full Text] [Related]
52. Efficacy of apomorphine and sildenafil in men with nonarteriogenic erectile dysfunction. A comparative crossover study. Perimenis P; Markou S; Gyftopoulos K; Giannitsas K; Athanasopoulos A; Liatsikos E; Barbalias G Andrologia; 2004 Jun; 36(3):106-10. PubMed ID: 15206909 [TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury. Giuliano F; Rubio-Aurioles E; Kennelly M; Montorsi F; Kim ED; Finkbeiner AE; Pommerville PJ; Colopy MW; Wilkins HJ; Wachs BH; Neurology; 2006 Jan; 66(2):210-6. PubMed ID: 16434656 [TBL] [Abstract][Full Text] [Related]
54. A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient? Hatzimouratidis K; Hatzichristou DG Drugs; 2005; 65(12):1621-50. PubMed ID: 16060698 [TBL] [Abstract][Full Text] [Related]
56. Sublingual apomorphine: a new pharmacological approach in Parkinson's disease? Montastruc JL; Rascol O; Senard JM; Houin G; Rascol A J Neural Transm Suppl; 1995; 45():157-61. PubMed ID: 8748621 [TBL] [Abstract][Full Text] [Related]
57. Brain activation patterns during video sexual stimulation following the administration of apomorphine: results of a placebo-controlled study. Montorsi F; Perani D; Anchisi D; Salonia A; Scifo P; Rigiroli P; Deho F; De Vito ML; Heaton J; Rigatti P; Fazio F Eur Urol; 2003 Apr; 43(4):405-11. PubMed ID: 12667722 [TBL] [Abstract][Full Text] [Related]
58. Up-titration of vardena fi l dose from 10 mg to 20 mg improved erectile function in men with spinal cord injury. Kimoto Y; Sakamoto S; Fujikawa K; Tachibana T; Yamamoto N; Otani T Int J Urol; 2006 Nov; 13(11):1428-33. PubMed ID: 17083398 [TBL] [Abstract][Full Text] [Related]
59. Electrophysiological actions of the dopamine agonist apomorphine in the paraventricular nucleus during penile erection. Richards N; Wayman C; Allers KA Neurosci Lett; 2009 Nov; 465(3):242-7. PubMed ID: 19733217 [TBL] [Abstract][Full Text] [Related]
60. Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury. Giuliano F; Rubio-Aurioles E; Kennelly M; Montorsi F; Kim ED; Finkbeiner AE; Pommerville PJ; Colopy MW; Wachs BH; Spine (Phila Pa 1976); 2008 Apr; 33(7):709-15. PubMed ID: 18379396 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]